Stryker Corporation

Stage 4 · Declining · week 6

As of Oct 22, 2026, Stryker is in Stage 4, the downtrend phase, now in week 6 (since Sep 16, 2026). It closed at $307.08, 20.1% below its 52-week high and below its 200-day average, which is falling.

Stryker Corporation operates as a medical technology company in the United States and internationally. More about the company

$307.08

+3.19% today

$118B · Large cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is SYK early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 19w

S2 31w

S2 16w

S4 17w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 3w → S3 6w → S4 7w → S1 2w → S2 19w → S3 11w → S2 4w → S3 3w → S2 31w → S3 8w → S2 1w → S1 1w → S2 16w → S3 5w → S4 17w → S1 4w → S4 17w → S1 8w → S4 5w current

Total tracked: 165 weeks across 19 stage runs.

SYK among Medical Devices62nd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…62	SYKStryker Corporation	Stage 4 · wk 6	41	+12.7%

vs 52W High

-20.1%

$268.90 lo$384.17 hi

20.1% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-5.2%

200 DMA: $323.85 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

1.03x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗ ⇈

Short-term trend rising gently, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+12.7%

-6.7%

-6.3%

YTD

-11.0%

-18.2%

Scan Membership

Breakout Watch

Latest: 2025-06-06

11 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 1.03x

2026-10-21S4

Wk 6 · Vol 0.73x

2026-10-20S4

Wk 5 · Vol 1.18x

2026-10-19S4

Wk 5 · Vol 1.15x

2026-10-16S4

Wk 5 · Vol 1.29x

2026-10-15S4

Wk 5 · Vol 1.20x

2026-10-14S4

Wk 5 · Vol 0.85x

2026-10-13S4

Wk 4 · Vol 0.79x

2026-10-12S4

Wk 4 · Vol 0.67x

2026-10-09S4

Wk 4 · Vol 0.54x

2026-10-08S4

Wk 4 · Vol 1.11x

2026-10-07S4

Wk 4 · Vol 0.71x

Moving averages & range

50 DMA

$295.85

200 DMA

$323.85

52W High

$384.17

52W Low

$268.90

5D Low

$294.66

Resistance levels (recent highs)

20d High

$307.08

60d High

$347.05

120d High

$351.14

250d High

$384.17

Next resistance

+13.0%

to 60d High

P/E (TTM)

31.8

Forward 18.4

Earnings Growth (YoY)

+44.1%

Revenue +9.4%

ROE

+16.5%

Profit margin +14.4%

Dividend Yield

1.18%

P/B 4.9

Stryker: quick answers

What stage is Stryker in?

As of Oct 22, 2026, Stryker (SYK) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 16, 2026 and is in week 6. What the four stages mean

Is Stryker in an uptrend?

No. Stryker is in a Stage 4 downtrend. It trades 5.2% below its 200-day average, which is falling.

How far is Stryker from its 52-week high?

Stryker closed at $307.08 on Oct 22, 2026, 20.1% below its 52-week high of $384.17. Its 52-week low is $268.90.

How has Stryker performed over the past year?

As of Oct 22, 2026, Stryker is down 18.2% over the past year and down 11.0% so far in 2026.

Which sector and industry is Stryker in?

Stryker is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.